Fulcrum Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC FULC

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

709

Value ($000)

8

Weight

0.0%

2022 Q1 - 2025 Q4 (8 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	8	0.0%	709	12/31/2025
2025 Q1	5/19/2025	2	0.0%	703	3/31/2025
2023 Q2	8/11/2023	73	0.0%	25,699	6/30/2023
2023 Q1	5/15/2023	73	0.0%	25,699	3/31/2023
2022 Q4	2/14/2023	108	0.0%	14,800	12/31/2022
2022 Q3	11/14/2022	120	0.0%	14,800	9/30/2022
2022 Q2	8/12/2022	73	0.0%	14,800	6/30/2022
2022 Q1	5/16/2022	350	0.0%	14,800	3/31/2022